HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of recreational drug 1,3 Dimethylamylamine (DMAA) [corrected] associated with cerebral hemorrhage.

Abstract
Dimethylamylamine (DMAA) was a forgotten pharmaceutical that was patented in 1944 as a nasal decongestant. DMAA has recently gained popularity as a dietary supplement, with claims of effectiveness as an athletic performance enhancer and weight loss aid. It is also sold as a recreational stimulant drug. DMAA is a sympathomimetic and potent pressor agent. This report describes 3 cases of cerebral hemorrhage in adults after the use of DMAA. The status of this substance as a synthetic or naturally occurring compound is also discussed.
AuthorsPaul Gee, Cheryl Tallon, Neil Long, Grant Moore, Ronald Boet, Suzanne Jackson
JournalAnnals of emergency medicine (Ann Emerg Med) Vol. 60 Issue 4 Pg. 431-4 (Oct 2012) ISSN: 1097-6760 [Electronic] United States
PMID22575212 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2012. Published by Mosby, Inc.
Chemical References
  • Ethylamines
  • Illicit Drugs
  • N,N-dimethylethylamine
Topics
  • Adult
  • Brain (diagnostic imaging, drug effects)
  • Cerebral Hemorrhage (chemically induced, diagnostic imaging)
  • Ethylamines (adverse effects)
  • Female
  • Humans
  • Illicit Drugs (adverse effects)
  • Male
  • Neuroimaging
  • Subarachnoid Hemorrhage (chemically induced, diagnostic imaging)
  • Substance-Related Disorders (complications, diagnostic imaging)
  • Tomography, X-Ray Computed
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: